header image
The world according to David Graham

Topics

acva bili chpc columns committee conferences elections environment essays ethi faae foreign foss guelph hansard highways history indu internet leadership legal military money musings newsletter oggo pacp parlchmbr parlcmte politics presentations proc qp radio reform regs rnnr satire secu smem statements tran transit tributes tv unity

Recent entries

  1. PMO Staff Run Government; Ministers Represent It
  2. On A Mostly Harmless Birthday
  3. The Trouble With Political Communications
  4. Politics: War By Other Means
  5. On the function of Social media
  6. C-18 is an existential threat, not a benefit, to democracy
  7. On Missing A Little More Than A Sub
  8. The Realpolitik Of Open Nomination
  9. What Is An Open Nomination, Really?
  10. Alberta election about identity, not policy
  11. The Trouble With Electoral Reform
  12. Mr. Bains Goes to Rogers
  13. Question Period
  14. Why do lockdowns and pandemic restrictions continue to exist?
  15. Parliamentary privilege: an arcane concept that can prevent coups
  16. It's not over yet
  17. Trump will win in 2020 (and keep an eye on 2024)
  18. A podcast with Michael Geist on technology and politics
  19. Next steps
  20. On what electoral reform reforms
  21. 2019 Fall campaign newsletter / infolettre campagne d'automne 2019
  22. 2019 Summer newsletter / infolettre été 2019
  23. 2019-07-15 SECU 171
  24. 2019-06-20 RNNR 140
  25. 2019-06-17 14:14 House intervention / intervention en chambre
  26. 2019-06-17 SECU 169
  27. 2019-06-13 PROC 162
  28. 2019-06-10 SECU 167
  29. 2019-06-06 PROC 160
  30. 2019-06-06 INDU 167
  31. older entries...

2017-10-05 15:12 House intervention / intervention en chambre

Committee studies and activities, Opposition motions, Pharmacare, Prescription drugs, Standing Committee on Health

Activités et études des comités, Comité permanent de la santé, Médicaments sur ordonnance

Mr. Speaker, this spring, at the procedure and House affairs committee, there was a fairly large blow-up when a bill arrived in our lap that apparently was related to a study that was under way at that time. I am sure the member from Hamilton remembers that quite well.

The member for Vancouver Kingsway, whose name this motion stands under, has brought forward this motion on the pharmacare program, which in its own right is not a bad thing. However, there is a study under way at the health committee, which has seen 89 witnesses over 20 meetings, to study this very issue. It has not finished that study. It is ongoing.

Therefore, I wonder if the New Democrats have respect for the process here after the biggest part of the blow-up came from that side on that bill, or if they are not really interested in the study actually considering it and just want the credit for the results.

Monsieur le Président, une crise a éclaté au comité de la procédure et des affaires de la Chambre au printemps dernier quand un projet de loi apparemment lié à une étude en cours à ce moment-là nous a été renvoyé. Je suis sûr que le député d'Hamilton s'en souvient très bien.

Le député de Vancouver Kingsway a présenté la motion sur le programme d'assurance-médicaments en son nom. Ce n'est pas une mauvaise chose en soi. Toutefois, il y a déjà une étude en cours au comité sur la santé exactement sur le même sujet; 89 personnes ont témoigné au cours de 20 réunions. L'étude n'est pas terminée. Elle se poursuit.

Les néo-démocrates n'ont-ils donc aucun respect pour le processus parlementaire? Après tout, c'est surtout eux qui avaient été dérangés par le projet de loi. Est-ce que, au fond, ils se fichent que l'étude explore vraiment la question parce qu'ils veulent simplement s'attribuer le mérite des résultats?

Watch | HansardEcoutez | Hansard

Posted at 13:26 on October 05, 2017

This entry has been archived. Comments can no longer be posted.

2017-10-05 PROC 72 | hansard parlchmbr tv |

2017-10-05 17:15 House intervention / intervention en chambre

(RSS) Website generating code and content © 2001-2020 David Graham <david@davidgraham.ca>, unless otherwise noted. All rights reserved. Comments are © their respective authors.